Genzyme is a pharmaceutical company that develops and commercializes drugs for rare diseases and multiple sclerosis.
Business Model:
Revenue: $1B
Employees: 1,001-5,000
Sanofi Genzyme was acquired by
Sanofi.
The acquisition happend on 2011-02-16.
Details of the transaction were not public
Address: 50 Binney Street
City: Cambridge
State: MA
Zip: 02142
Country: US
Genzyme is a pharmaceutical company that develops and commercializes drugs for rare diseases and multiple sclerosis.
Contact Phone:
Contact Email:
Listed Exchange:
NYSE
Ticker Symbol:
SNY
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
9/2008 | Humanigen | Series D | 0 |
6/2006 | Peptimmune | Series C | 0 |
1/2014 | Alnylam Pharmaceuticals | Post-IPO Equity | 0 |
2/2015 | Voyager Therapeutics | Corporate Round | 0 |
2/2015 | Voyager Therapeutics | Corporate Round | 0 |
1/2014 | Alnylam Pharmaceuticals | Post-IPO Equity | 0 |
9/2008 | Humanigen | Series D | 0 |
6/2006 | Peptimmune | Series C | 0 |
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2020 | Debt | $2.9M |
IDA Ireland |
6/1981 | Unattributed | $3M |
Oak Investment Partners |
6/1986 | IPO | $28.2M |
---|
Announced Date | Name | Price |
---|---|---|
5/2007 | Bioenvision | |
10/2006 | AnorMED | |
7/2005 | BoneCare International | |
2/2005 | Verigen | |
12/2004 | ILEX Oncology,Inc. | |
9/2003 | SangStat | |
12/2000 | Biomatrix | |
6/1997 | Pharmagenics |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|